Israel


Innocan Pharma Reports a Successful FDA-Required Characterization of Highly CBD-Loaded Liposome Platform

March 28th, 2022 - Ryan Allway

Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – March 28, 2022) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the “Company” or “Innocan”), is pleased to report the successful completion of Innocan’s CBD Liposome drug-product physico-chemical characterization.   Physico-chemical characterization is an important part of the application package to be submitted to the FDA. […]

InterCure Announces Partnership with Altman Health

March 1st, 2022 - Ryan Allway

The partnership will focus on the new CBD wellness market in Israel Israeli Minister of Health announced yesterday that CBD will be removed from the Dangerous Drugs Act Altman Health is the market leader in health and wellness with distribution across the country NEW YORK and TORONTO and HERZLIYA, Israel, March 01, 2022 (GLOBE NEWSWIRE) […]

Isracann Signs LOI to Acquire Natural Health Medicine Developer

February 23rd, 2022 - Ryan Allway

VANCOUVER, British Columbia, Feb. 23, 2022 (GLOBE NEWSWIRE) — Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) a biosciences company focused on researching and developing innovative health solutions in conjunction with its advanced stage activities aimed at becoming a premier low-cost, high-quality cannabis producer/distributor is pleased to announce that it […]

Canonic Announces Professor Itamar Grotto Joining its Board of Directors

February 16th, 2022 - Ryan Allway

 Professor Grotto is a world-renowned expert in public health; As former Associate Director General at the Israeli Ministry of Health he led the medicalization reform of cannabis in Israel   Rehovot, Israel – February 16, 2022 – Canonic Ltd., focused on the development of medical-grade cannabis products and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ: EVGN, TASE: EVGN), […]

Canonic Announces Shipment of its Cannabis Varieties to Europe

January 31st, 2022 - Ryan Allway

Canonic is the first Israeli company shipping cannabis varieties from Israel to Europe, towards planned commercial launch in Europe in 2023   Rehovot, Israel – January 31, 2022 – Canonic Ltd., focused on the development of medical grade cannabis products and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ: EVGN, TASE: EVGN), announced today that it has shipped a […]

SciSparc Presents New Leadership Lineup

January 27th, 2022 - Ryan Allway

TEL AVIV, Israel, Jan. 27, 2022 /PRNewswire/ — SciSparc Ltd. (NASDAQ: SPRC) a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the “Company”), announced that its board of directors (the “Board”) resolved to appoint Mr. Oz Adler as the Chief Executive Officer, Mr. Itschak Shrem as the President of […]

Save Foods Enters into Distribution Agreement with Cannabis Producer BRLEV AGRICULTURAL CROPS LTD. to Address Contamination in Cannabis Products

January 6th, 2022 - Ryan Allway

Microbial contamination projected to cost cannabis industry $3 billion Tel Aviv, Israel, Jan. 06, 2022 (GLOBE NEWSWIRE) — Save Foods (NASDAQ: SVFD) (“Save Foods” or the “Company”), an Israeli Agri-Food Tech company announced today a distribution agreement with Israeli cannabis company BRLEV AGRICULTURAL CROPS LTD. (“BRLev”) to provide Save Foods’ eco crop protection treatment as a white […]

Aurora Cannabis Delivers ~$10 Million Shipment of Medical Cannabis to Israel

January 4th, 2022 - Ryan Allway

• Believed to be the largest shipment of medical cannabis to Israel to-date • Aurora continues to advance strategic leadership in the global cannabinoid industry   EDMONTON, AB, Jan. 4, 2022 /CNW/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the delivery of a cannabis shipment worth […]

AVANT COMMENCES CANNABIS EXPORT SHIPMENTS TO ISRAEL

October 13th, 2021 - Ryan Allway

Kelowna, BC, Oct. 13, 2021 (GLOBE NEWSWIRE) — Avant Brands Inc. (TSX: AVNT) (OTCQX: AVTBF) (FRA: 1BUP) (“Avant” or the “Company”), an award-winning leading producer of handcrafted, high quality cannabis products, announces that its wholly-owned subsidiary, Grey Bruce Farms Inc. (“GBF”),  has completed its first international export shipment to a leading medical cannabis company in Israel.  The initial shipment of over 200 kilograms (“KG”) of cannabis was made by GBF to Focus Medical Herbs Ltd., an Israeli licensed producer with exclusive agreements with IM […]

Evogene Reports Second Quarter 2021 Financial Results

August 11th, 2021 - Ryan Allway

– Evogene’s management provides update on its plans for unlocking the value of its subsidiaries – Conference call and webcast: today, August 11, 2021, 9:00 am ET   REHOVOT, Israel, Aug. 11, 2021 /PRNewswire/ — Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development across several market segments, announced […]

Ayurcann Signs New Manufacturing and Distribution Agreement with Innocan Pharma

August 11th, 2021 - Ryan Allway

TORONTO, Aug. 11, 2021 (GLOBE NEWSWIRE) — Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”), a Canadian extraction company specializing in the processing of cannabis and hemp to produce oils and various derivative products, is pleased to announce that it has entered into a manufacturing and distribution agreement with Innocan Pharma Corporation (“Innocan”), an […]

SciSparc to Commence Phase IIa Clinical Trial of SCI-110 for the Treatment of Alzheimer’s Disease and Agitation

July 7th, 2021 - Ryan Allway

Trial will be conducted at the Israeli Medical Center for Alzheimer’s and will evaluate the safety, tolerability and efficacy of SCI-110   TEL AVIV, Israel, July 7, 2021 /PRNewswire/ — SciSparc Ltd. (formerly known as Therapix Biosciences Ltd.) (OTCQB: SPRCY) a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous […]

Company set to manufacture and sell proprietary products for Bazelet in Canada

June 8th, 2021 - Ryan Allway

TORONTO, June 08, 2021 (GLOBE NEWSWIRE) — Ayurcann Holdings Corp. (CSE: AYUR) (the “ Company ” or “ Ayurcann ”), a Canadian extraction company specializing in the processing of cannabis and hemp to produce oils and various derivative products, is pleased to announce that it has entered into a joint venture agreement to manufacture proprietary products with Bazelet Nehushtan […]

Toronto Stock Exchange, InterCure, C-Suite at The Open

June 7th, 2021 - Ryan Allway

TORONTO, June 7, 2021 /CNW/ – Ehud Barak, Israel’s former Prime Minister and Chairman, InterCure Ltd., (“InterCure” or the “Company”) (TSX: INCR.U), shares his Company’s story in an interview with TMX Group.   The C-Suite at The Open video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange and TSX Venture Exchange.  Videos provide insight into how company executives think […]

The Flowr Corporation Announces Export Agreement to Israel with Focus Medical Herbs and IM Cannabis

June 7th, 2021 - Ryan Allway

Flowr to export up to 500 kilograms of premium medical cannabis to Israel. The Supply Agreement represents the Company’s first export opportunity into an international market.   TORONTO, June 07, 2021 (GLOBE NEWSWIRE) — The Flowr Corporation (TSX.V: FLWR; OTC: FLWPF) (“Flowr” or the “Company”) is pleased to announce that it has entered into a […]

IMC Reports First Closing of the Panaxia Acquisition and Provides Update on Canadian Business Activities

June 1st, 2021 - Ryan Allway

Launches WAGNERS brand with new cultivars and SKUs MYM shareholder meeting set for July 5, 2021 Substantially completes loan portfolio run-off and realizes a 24% IRR     TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / June 1, 2021 / IM Cannabis Corp. (“IMC” or the “Company“) (CSE:IMCC), (NASDAQ:IMCC), a multi-country operator (“MCO“) in the […]

MindMed Announces Launch of Collaboration with Nextage Therapeutics’ Brain Targeting Liposome System

May 24th, 2021 - Ryan Allway

NEW YORK, May 24, 2021 /CNW/ — MindMed (NASDAQ: MNMD, NEO: MMED, DE: MMQ), a leading clinical stage psychedelic medicine company, and Nextage Therapeutics (TASE: NXTG), an Israeli innovative drug development company, announce the execution of a Memorandum of Understanding (the “MOU”) regarding the launch of an exclusive collaborative development program to optimize the delivery […]

DNA Genetics Announces Strategic Alliance Agreement With Vertically-Integrated Israeli Cannabis Company, UNIVO Pharmaceuticals

May 10th, 2021 - Ryan Allway

LOS ANGELES, May 10, 2021 (GLOBE NEWSWIRE) — OG DNA Genetics (“DNA” or the “Company”), a globally recognized leading cannabis brand, today announced a licensing agreement (the “Agreement”) with UNIVO Pharmaceuticals LTD (“UNIVO”), an Israeli based medical cannabis company trading on the Tel Aviv stock exchange under the symbol UNVO.TA.   This Agreement will grant […]

IM Cannabis Acquires Israel’s Largest Retail and Online Pharmacy Business from Panaxia, Creating a Vertically Integrated Global Platform for the IMC Brand

April 30th, 2021 - Ryan Allway

With Israel‘s Fast-Paced E-Commerce Adoption and Cannabis Market’s High Growth Rate (Averaging 4 Percent1 per Month), Panaxia’s Online Platform to Support Patient Base Expansion   Acquisition Broadens IMC’s Patient Offering in Israel, Facilitates Stronger Direct Patient Relationships and Enables the Company to Grow its IMC Brand Awareness   Offers Additional Opportunity to Generate Revenue and Margin on […]

Cannabics Pharmaceuticals Launches a New Research Program to develop a Melanoma Treatment Drug Candidate for FDA Approval Track

April 26th, 2021 - Ryan Allway

TEL AVIV, Israel and BETHESDA, Maryland, April 26, 2021 /PRNewswire/ — Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today the launching of a new research program for the development of a Melanoma antitumor targeting medicine. The announcement comes amidst the recent completion of a series of preclinical experiments within the company’s […]

BioHarvest Sciences Inc. Delivers Record First Quarter Sales Performance of VINIA in Israel

April 7th, 2021 - Ryan Allway

Q1 sales orders in line to achieve or exceed revised annual projections. Vancouver, British Columbia–(Newsfile Corp. – April 7, 2021) – BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) announced today that sales orders of VINIA® in Q1/2021 reached an all-time high of US$ 377,756, representing a 17% increase over Q4/2020 sales orders, and a 668% […]

Subversive Acquisition LP Announces InterCure’s Letter of Intent Relating to the Acquisition of a Multi-National Medical Cannabis Producer, Better Holdings

April 5th, 2021 - Ryan Allway

InterCure Signs Letter of Intent with Cann Pharmaceutical Ltd. Acquisition Strengthens InterCure’s Position as the Largest Cannabis Company Outside of North America TORONTO, April 05, 2021 (GLOBE NEWSWIRE) — SUBVERSIVE ACQUISITION LP (TSX: SVX.U, NEO: SVX.U, OTCQX: SBVRF) (“SVX”) announced today that InterCure Ltd. (dba Canndoc) (TASE: INCR) (“InterCure”), Israel’s leading cannabis company and SVX’s intended target […]

Subversive Acquisition LP Announces InterCure’s Letter of Intent Relating to the Acquisition of a Multi-National Medical Cannabis Producer, Better Holdings

April 5th, 2021 - Ryan Allway

InterCure Signs Letter of Intent with Cann Pharmaceutical Ltd. Acquisition Strengthens InterCure’s Position as the Largest Cannabis Company Outside of North America TORONTO, April 05, 2021 (GLOBE NEWSWIRE) — SUBVERSIVE ACQUISITION LP (TSX: SVX.U, NEO: SVX.U, OTCQX: SBVRF) (“SVX”) announced today that InterCure Ltd. (dba Canndoc) (TASE: INCR) (“InterCure”), Israel’s leading cannabis company and SVX’s intended target […]

Israel Gives Final Go-Ahead for Cannabis Exports: Here’s Who Could Profit

June 5th, 2020 - Ryan Allway

Israel gave final approval in mid-May for exports of medical cannabis, paving the way for more than one billion shekels ($273 million) in annual revenue. The country will become one of just three countries that have approved the export of medical cannabis to countries that permit its use—after Canada and the Netherlands— when the law […]

How to Invest in a Global Cannabis Portfolio

May 20th, 2020 - Ryan Allway

North America’s cannabis industry may capture the most headlines, but there are many cannabis frontier markets to keep in mind. In fact, North America represented just 25%, or $86 billion, of the $344 billion global cannabis market in 2018, according to New Frontier Data. Asia, Europe, Africa, Latin America, Oceana and the Caribbean are all […]

Israel Begins Cannabis Exports to Meet Unmet Medical Needs

March 30th, 2020 - Ryan Allway

Israel has long been an international center for cannabis research. THC, the psychoactive ingredient in cannabis, and CBD, the plant’s predominant non-psychoactive ingredient, were first isolated and defined by Israeli researcher Dr. Raphael Mechoulam in the early 1960s. Research continued there in the following decades, and the Israeli government has contributed greatly to the country’s […]

Isracann Enters JV for Near-Term Cannabis Farm Production Opportunity in Israel

March 24th, 2020 - Ryan Allway

24 MAR 2020 / CORPORATE NEWS Partnership advances time-to-market to under six months VANCOUVER, BC, — (March 24, 2020) – Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is […]

Investors Opening Eyes to Opportunity in Israel Cannabis, Including Exclusive CEO Video Interview Part #2

December 23rd, 2019 - Ryan Allway

There is no country on Earth that has a history steeped in cannabis research like that of Israel. Furthermore, there is no government that is more supportive of medical marijuana research than Israel. Yet, the small country has by and large gone overlooked for what it has to offer as an investment opportunity. That is […]

Isracann Closer to Greenhouse Construction as Israel Cannabis Market Heats Up

December 10th, 2019 - Ash Stringer

Israel has long been recognized for its pioneering contributions to research in the medical cannabis field. Recently, the state made its commitment clear to develop the sector by issuing a white paper on the opportunity to invest in Israeli cannabis. That was followed by the largest medical-marijuana merger ever in the country, with Cannbit Pharmaceuticals […]

Israel Writing Playbook to Become Cannabis Gateway to Europe

November 21st, 2019 - Ash Stringer

With unprecedented expertise in cannabis research and perfect weather conditions for cultivation, it only makes sense that Israeli lawmakers took a global leadership position in January 2019 by green-lighting the export of medical cannabis to countries where it is allowed. Then it just became a matter of establishing the framework to become one of only […]


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading